Activated CD8 T-lymphocytes in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 820-828 Year: 2005
Monocytes inhibit NK activity via TGF-ß in patients with obstructive sleep apnoea Source: Eur Respir J, 49 (6) 1602456; 10.1183/13993003.02456-2016 Year: 2017
Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea? Source: Eur Respir J 2008; 32: 113-120 Year: 2008
Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea Source: Eur Respir J 2009; 33: 1077-1084 Year: 2009
Treatment of obstructive sleep apnea and the cytotoxic potential in peripheral blood lymphocytes Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Selective activation of pro-inflammatory cytokines in obstructive sleep apnoea syndrome and impact of CPAP Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Relationship between obstructive sleep apnea and human leukocyte antigen variants Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Circulating dendritic cell subsets are reduced in obstructive sleep apnoea patients: study correlation with inflammation markers Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019
Decreased circulating endothelial progenitor cells in obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Source: Eur Respir J 2008; 32: 1009-1015 Year: 2008
Low circulating levels of invariant natural killer T (iNKT) cells in patients with obstructive sleep apnoea syndrome and impaired functional response to hypoxia: Implications for cancer co-morbidity Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013
Serum leukotriene B4 levels, tonsillar hypertrophy and obstructive sleep-disordered breathing in childhood Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults Year: 2015
Differential regulation of cytokine production is mediated by IL-17 in obese children with obstructive sleep apnoea Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016
Effect of nCPAP therapy on inflammatory cell counts in pharyngeal lavage of patients with obstructive sleep apnea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009
Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003
Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
Leukotriene B4 receptor blockade increases apoptosis of monocyte-derived macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS) Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015
Production of TNF-α, MMPs, and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004